Law360 (February 12, 2020, 5:42 PM EST) -- While prescription drug costs remain a major concern of American voters, the public debate has focused largely on federal initiatives. The Trump administration has made drug pricing a centerpiece of its health care agenda, and key congressional leaders from both parties have introduced competing legislation. However, thus far, few consequential policies have been implemented at the federal level.
A different picture emerges at the state level where, over the past few years, state governors and legislatures have been quietly leading the charge on drug pricing initiatives. In 2019 alone, state legislators introduced roughly 300 drug pricing bills, and 37 states enacted...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!